Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
US scientists win Nobel Prize for Medicine for discovering microRNA
American researchers Victor Ambros and Gary Ruvkun have been awarded the 2024 Nobel Prize in Physiology or Medicine for their pioneering discovery of microRNA.
Gilead expands access to PrEP HIV candidate in 120 countries
A new licensing agreement from Gilead Sciences and six generic drug manufacturers is poised to transform HIV prevention efforts
AZ's Dr Sunil Verma on the next chapter in cancer care
Ever wondered what one of the world’s top oncology leaders believes to be the next big thing in cancer care? Find out in our interview AstraZeneca’s Dr Sunil Verma.
ViiV Healthcare’s Jean-Bernard Simeon on ending the HIV epidemic
Join JB, ViiV Healthcare Europe to explore the HIV landscape in Europe, the UNAIDS plan to end the epidemic by 2030 and more in this podcast.
Genentech acquires Regor’s next-gen CKD inhibitor portfolio
Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth $850M.
Sanofi and Regeneron's allergy drug is first biologic for COPD
Sanofi and Regeneron have announced that dupilumab has received an FDA approval in COPD and an eosinophilic phenotype.
Novo Nordisk expands stem cell research arm with Evotec
Evotec has joined forces with Novo Nordisk to advance the clinical and commercial manufacturing of stem cell-based therapies.
Cracking compliance in the US: Key points for pharma to remember
What key compliance considerations should pharma companies keep in mind before releasing new research in the US market, and how can they avoid compliance pitfalls?
Moderna’s Chantal Friebertshäuser on improving vaccine confidence
The EMJ GOLD podcast is back! Our first guest is Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna.
US to donate 1 million mpox vaccines to Africa amid outbreak
In response to the ongoing mpox outbreak in parts of Africa, the US government has announced a significant donation of 1 million vaccines.
←
1
2
3
…
32
33
34
35
36
37
38
…
66
67
68
→
We’ve noticed you’re accessing
from
North/South America.
View
View